Dyslipidemia Is Related to Mortality in Critical Patients With Coronavirus Disease 2019: A Retrospective Study
BackgroundIt has been reported that dyslipidemia is related to coronavirus-related diseases. Critical patients with coronavirus disease 2019 (COVID-19) who suffered from multiple organ dysfunctions were treated in the intensive care unit (ICU) in Wuhan, China. Whether the lipids profile was associat...
Main Authors: | Jiang Yue, Hua Xu, Yong Zhou, Wen Liu, Xiaofeng Han, Qing Mao, Shengxian Li, Lai-Shan Tam, Jing Ma, Wei Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2021.611526/full |
Similar Items
-
Association between platelet parameters and mortality in coronavirus disease 2019: Retrospective cohort study
by: Yanli Liu, et al.
Published: (2020-05-01) -
Efficacy of ivermectin in patients with coronavirus disease 2019 pneumonia with severe and critically ill status
by: Ahmed A Elesdoudy
Published: (2022-01-01) -
Predictors of mortality among Egyptian hemodialysis patients with coronavirus disease 2019: a multicenter retrospective cohort
by: Enass E El-Sayed, et al.
Published: (2021-01-01) -
Association between Nafamostat Mesylate and In-Hospital Mortality in Patients with Coronavirus Disease 2019: A Multicenter Observational Study
by: Ryota Inokuchi, et al.
Published: (2021-12-01) -
Assessment of interleukin-6 role in detecting coronavirus disease 2019 severity, mortality, and its control: A cohort study
by: Heba M Shalaby, et al.
Published: (2023-01-01)